EMA regular press briefing on COVID-19
The European Medicines Agency (EMA) is holding a fortnightly press briefing to provide an update on EMA's COVID-19 activities.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Monika Benstetter (Head of Media and Public Relations).
EMA will still organise ad-hoc press conferences as necessary and appropriate.
The press briefing will be held in English. No translations will be provided.